Mon – Fri | 8:00 am – 6:00 pm
Sat – Sun | closed

Refer a patient for Spravato® (esketamine)

We are a REMS-certified Spravato® (esketamine) treatment center in Renton, serving adults across Washington. Send us your patient’s information and our team handles eligibility, insurance, and monitoring, while keeping you informed at every step.

Questions? Call (425) 233-0431 or email office@opmhs.com, Attn: Spravato Referrals.

Spravato is for adults with treatment-resistant depression. Refer a patient who fits any of the following.

Has major depressive disorder and has not responded to two or more antidepressant trials at an adequate dose and duration.
Has MDD with acute suicidal ideation or behavior and needs rapid intervention.
Cannot tolerate or prefers not to take a daily oral antidepressant.
Needs faster relief than oral antidepressants typically provide.

As of January 2025, Spravato is approved as a monotherapy for treatment-resistant depression. Your patient no longer needs to be on a daily oral antidepressant to be eligible, which opens the door for many more patients.

No waitlist. New patients are scheduled quickly and contacted within one business day.
Streamlined and managed insurance process. We accept most major commercial plans and handle any necessary authorizations
Multi-modality care under one roof: Spravato, medication management, therapy, and GeneSight testing.
As low as $10 per session for eligible, commercially insured patients through the SPRAVATO withMe Savings Program.
A calm, private, supervised setting designed for comfort and safety, with attentive support throughout each treatment session.
Established since 2013. A women-owned psychiatric practice your patients can trust.
Send the referral
Download the form, then fax it to (425) 329-8087, or call us with your patient’s information.
We handle the rest
Our team verifies benefits, confirms eligibility, obtains prior authorization, and schedules your patient quickly.
You stay informed
We administer and monitor each session per REMS guidelines and send progress updates back to you.
Benefits verification
We confirm coverage and explain out-of-pocket costs before the first visit.
Prior authorization
Our billing team manages the prior auth process from start to finish.
REMS monitoring
Each dose is administered and monitored in our certified setting per REMS.
Spravato With Me enrollment
We enroll eligible patients and help identify cost and transportation support.
Progress updates
We report back so you stay your patient’s anchor and continuity of care.
Coordinated care
You continue medication management as appropriate. We coordinate, not take over.

Please include: diagnosis and reason for referral, prior antidepressant trials (medication, dose, duration, response), current medications, relevant risk and safety history, and insurance information.

How quickly will my patient be seen?
arrow down

We do not keep a waitlist. Once we have the referral and confirm benefits, we schedule promptly and contact your patient within one business day.

Do you handle insurance and prior authorization?
arrow down

Yes. We manage the full insurance process for treatment, including prior authorization and benefits verification. We will also review any expected out-of-pocket costs with patients before starting care so there are no surprises.

Will I stay involved in my patient’s care?
arrow down

Yes. You continue medication management as appropriate, and we send progress updates. We coordinate with you rather than take over the relationship.

What documentation should I send?
arrow down

The referral form covers it: diagnosis, prior antidepressant trials, current medications, relevant risk and safety history, and insurance. A recent progress note is helpful but optional.

Can a patient who is not on a daily antidepressant qualify?
arrow down

Yes. Following the 2025 monotherapy approval, eligible patients can receive Spravato without a
concurrent oral antidepressant.